 |
PDBsum entry 4ji9
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4ji9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
23:5014-5021
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitors.
|
|
M.Siu,
R.Pastor,
W.Liu,
K.Barrett,
M.Berry,
W.S.Blair,
C.Chang,
J.Z.Chen,
C.Eigenbrot,
N.Ghilardi,
P.Gibbons,
H.He,
C.A.Hurley,
J.R.Kenny,
S.Cyrus Khojasteh,
H.Le,
L.Lee,
J.P.Lyssikatos,
S.Magnuson,
R.Pulk,
V.Tsui,
M.Ultsch,
Y.Xiao,
B.Y.Zhu,
D.Sampath.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The advancement of a series of ligand efficient
2-amino-[1,2,4]triazolo[1,5-a]pyridines, initially identified from
high-throughput screening, to a JAK2 inhibitor with pharmacodynamic activity in
a mouse xenograft model is disclosed.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |